CJC-1295 / Ipamorelin 5/5mg Blend (No DAC)

Comprehensive Laboratory Profile

The acquisition of high-fidelity, dual-analog formulations is essential for laboratories investigating synergistic endocrine signaling. The CJC-1295 Ipamorelin 5/5mg blend provides institutional researchers with a premium, highly purified system engineered for advanced in-vitro analysis of pituitary growth hormone (GH) secretagogue pathways.

Synthesized in the USA to the highest industry standards, this blend delivers the analytical precision required by modern facilities. Utilizing the CJC-1295 Ipamorelin 5/5mg compound ensures your facility obtains definitive, reproducible data free from the inconsistencies found in lower-purity research materials.

Biochemical Profile: Synergistic Secretagogue Blend

This formulation combines two distinct classes of GH secretagogues. CJC-1295 (without DAC) acts as a GHRH analog, stimulating the GHRH receptor, while Ipamorelin functions as a highly selective ghrelin receptor (GHS-R) agonist.

In an isolated laboratory environment, combining these two analogs allows researchers to study the amplified GH secretory response that occurs when both receptor populations are engaged simultaneously. This dual-pathway stimulation is a critical model for understanding complex endocrine feedback loops.

Mechanism of Action

When introduced to anterior pituitary cell cultures, the CJC-1295 Ipamorelin 5/5mg blend initiates a robust intracellular cascade. The CJC-1295 component elevates intracellular cAMP, while Ipamorelin facilitates the influx of calcium ions through ghrelin receptor activation.

The convergence of these pathways results in a significant, synergistic increase in GH release compared to independent administration. Researchers utilize this compound to map binding kinetics and receptor cross-talk in various pituitary cell isoforms.

Primary Research Applications

The versatility and synergistic potential of this blend make it a foundational tool for metabolic and endocrine studies.

Current scientific literature utilizes the CJC-1295 Ipamorelin 5/5mg compound primarily for:

• Synergistic Secretagogue Assays: Mapping the amplified secretory output of pituitary cells.

• Receptor Cross-Talk Modeling: Investigating the interplay between GHRH and ghrelin signaling cascades.

• Proteolytic Stability Analysis: Utilizing this compound as a control in studies involving modified GH analogs.

• Cellular Metabolism Assays: Using the CJC-1295 Ipamorelin 5/5mg blend to document endocrine response under simulated physiological stress.

Purity and Quality Assurance

At Ion Peptides, we recognize that anomalous data from impure materials compromises research outcomes. Every batch of our CJC-1295 Ipamorelin 5/5mg blend is subjected to rigorous, third-party analytical testing.

We utilize High-Performance Liquid Chromatography (HPLC) to verify a purity threshold of >99.0%. This ensures the isolation of both active peptides from residual solvents or truncated sequences.

Furthermore, Mass Spectrometry (MS) is employed to verify the precise molecular weight of both components. By securing your CJC-1295 Ipamorelin 5/5mg supply through our USA synthesis network, you guarantee materials that meet the highest echelons of analytical compliance.

Storage and Reconstitution

The CJC-1295 Ipamorelin 5/5mg vial is supplied as a lyophilized (freeze-dried) powder to ensure molecular stability.

• Storage: Store vials in a climate-controlled environment at or below -20°C. Protected from light and moisture, the powder remains stable for up to 36 months.

• Reconstitution: Utilize sterile bacteriostatic water.

  1. Allow the vial to reach room temperature before opening.

  2. Introduce the diluent slowly, letting it flow down the interior glass wall.

  3. Do not vortex or shake. Allow the CJC-1295 Ipamorelin 5/5mg compound to dissolve via gentle, rotational swirling.

  4. Store reconstituted solution at 2°C to 8°C and utilize within standard laboratory protocol timelines.